Abstract
Andrew Sargisson, regional medical director of the global Sumitomo (SHI) Demag team, shares his industry insight and global predictions for the medical market, and how these latest trends are influencing investments in medical injection moulding facilities worldwide.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have